CAS 388592-44-7

CK-0157869

CAS : 388592-44-7

Formule : C₁₇H₁₆BrNO₃S

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 394.2828

Ref: IN-DA00CNAH

2-(3-Bromophenyl)-3-(2,4-Dimethoxyphenyl)Thiazolidin-4-One

CAS : 388592-44-7

2-(3-Bromophenyl)-3-(2,4-Dimethoxyphenyl)Thiazolidin-4-One

Degré de pureté : 98%

Masse moléculaire : 394.28g/mol

Ref: 54-OR1009727

CK-869

CAS : 388592-44-7

CK-869

Degré de pureté : ≥98%

Masse moléculaire : 394.28g/mol

Ref: 54-BUP10312

CK-869

CAS : 388592-44-7

CK-869 is an Actin-Related Protein 2/3 (ARP2/3) complex inhibitor(IC50 of 7 μM),and is useful tools for the investigation of the Arp2/3 complex.

Formule : C₁₇H₁₆BrNO₃S

Degré de pureté : 99.85%

Couleur et forme : Solid

Masse moléculaire : 394.28

Ref: TM-T5860

CK 869

CAS : 388592-44-7

CK869 is a molecule that has been shown to inhibit cancer cells and induce apoptosis in vitro. This drug binds to actin subunits and inhibits the function of actin filaments. CK869 has also been shown to stimulate autophagy, which is a process by which cells degrade their own cellular components. CK869 may be useful for treating infectious diseases such as tuberculosis, malaria, and HIV. It has also been found to have anti-inflammatory properties, suggesting that it may be an effective treatment for autoimmune disorders such as multiple sclerosis or rheumatoid arthritis.

Formule : C₁₇H₁₆BrNO₃S

Degré de pureté : Min. 95%

Masse moléculaire : 394.28 g/mol

Ref: 3D-NQA59244